TY - JOUR
T1 - Both substance P agonists and antagonists inhibit ion conductance through nicotinic acetycholine receptors on PC12 cells
AU - Eardley, David
AU - McGee, Richard
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1985/8/7
Y1 - 1985/8/7
N2 - Substance P stimulates substance P receptors but also inhibits ion conductance through nicotinic acetylcholine receptors. Substance P analogs, classified as agonists or antagonists based on their actions on smooth muscle, were tested to determine if they also could act at nicotinic receptors on the pheochromocytoma, PC12. All of the analogs tested, [D-Pro2, D-Trp7,9]SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]SP, [pGlu5, MePhe8, Sar9]SP-(5-11), and [D-Pro4, D-Trp7,9,10]SP-(4-11), inhibited agonist-induced uptake of 86Rb+ through the nicotinic receptors at concentrations quite similar to those required for action at substance P receptors on smooth muscle. Thus, the chemical modifications in the analogs do not substantially alter their ability to inhibit nicotinic receptors.
AB - Substance P stimulates substance P receptors but also inhibits ion conductance through nicotinic acetylcholine receptors. Substance P analogs, classified as agonists or antagonists based on their actions on smooth muscle, were tested to determine if they also could act at nicotinic receptors on the pheochromocytoma, PC12. All of the analogs tested, [D-Pro2, D-Trp7,9]SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]SP, [pGlu5, MePhe8, Sar9]SP-(5-11), and [D-Pro4, D-Trp7,9,10]SP-(4-11), inhibited agonist-induced uptake of 86Rb+ through the nicotinic receptors at concentrations quite similar to those required for action at substance P receptors on smooth muscle. Thus, the chemical modifications in the analogs do not substantially alter their ability to inhibit nicotinic receptors.
KW - Nicotinic acethylcholine receptors
KW - PC12 cells
KW - Substance P
UR - http://www.scopus.com/inward/record.url?scp=0022204005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022204005&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(85)90529-1
DO - 10.1016/0014-2999(85)90529-1
M3 - Article
C2 - 2412850
AN - SCOPUS:0022204005
SN - 0014-2999
VL - 114
SP - 101
EP - 104
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -